GLP1R and gastroesophageal reflux disease: Role of semaglutide in exacerbate symptoms of gastroesophageal reflux disease in patients with existing diagnoses and may induce gastroesophageal reflux in patients who are genetically predisposed to it due to the delayed gastric emptying effects of GLP-1 agonists was also reported [98].